Skip to main content

Table 2 Statistical analysis

From: The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner

Group Comparisons* Χ 2 P-Value
Bz v. Control 0.868 0.349
Bz → HB v. Control 1.044 0.307
HB → Bz v . Control 3.884 0.049
Bz → HB v. Bz 0.001 0.972
HB → Bz v. Bz 1.058 0.304
HB → Bz v. Bz →HB 1.324 0.250
  1. * Statistical comparisons between groups were calculated as described in Materials and Methods. The arrow denotes the order of treatments. Bz = Bortezomib, HB = HB 22.7. N = 5 mice per group; p < 0.05 is considered significant.